Tevogen Bio Holdings Inc

TVGN is consolidating in Early Stage 1 with a Post-Capitulation pattern indicating exhausted selling and supply absorption. Medium-term bias is set to bullish on the asymmetry from exhaustion, but short-term timing is neutral amid flat EMAs and overbought indicators. Execution is deferred, stalking for pullbacks into the repaired EMA regime or decisive upside acceptance above recent highs.

• ↑Analysts project $39.72 in 30 days, $42.45 in 2026, $167.03 by 2030
• ↑Liquidity score 0.77 suggests adequate cash reserves for R&D
• ↓Earnings yield -2.84 and profitability score -1.69 highlight weak returns